Officials insist Canada still on track for 4M Pfizer doses by March despite planning data - Global News | Canada News Media
Connect with us

Business

Officials insist Canada still on track for 4M Pfizer doses by March despite planning data – Global News

Published

 on


Come hell or high water, the Prime Minister’s Office insists the country will get the promised four million doses of Pfizer’s coronavirus vaccine by the end of March.

It comes after a chaotic morning of questions prompted by planning data sent by the federal government to provinces, who promptly raised the alarm at the numbers showing they could receive only 3.5 million doses rather than four million.

But officials insisted those numbers are only “minimums” and come amid a push by Pfizer to get Health Canada to approve squeezing an extra dose out of each vial of vaccine.

Read more:
Pfizer pushes Health Canada to stretch vaccine doses per vial as demand mounts

“Pfizer certainly intends on fulfilling their contractual obligations,” Gen. Dany Fortin, who is overseeing logistical planning for Canada’s vaccine distribution efforts, told reporters in Ottawa on Thursday.

Story continues below advertisement

“We are providing as much visibility as possible to the provinces and territories.”

Sources from multiple premiers’ offices told Global News Thursday that data provided to them by federal officials showed that Canada’s goal of four million vaccines by March had been reduced to 3.5 million.

One source told Global News that Alberta’s total shipments under that timeline could be 13 per cent less than previously expected.






3:04
Pfizer wants to relabel COVID-19 vaccine vials from 5 to 6 doses


Pfizer wants to relabel COVID-19 vaccine vials from 5 to 6 doses

Fortin said the data was for provinces to “plan against” and was “a baseline” provinces can build on while sorting out vaccination logistics.

“The numbers are accurate in terms of planning, but we know those numbers will grow to meet the target of four million doses by the end of March,” Fortin said.

Story continues below advertisement

“There’s a number of variables still at play.”

The key variable is whether Health Canada approves a request from the company to boost the number of doses it extracts from each vial of the vaccine from five to six.

It would allow the company to send fewer vials to Canada, while still meeting its contractual obligations.






1:00
Coronavirus: Over 902,000 COVID-19 vaccine doses administered across Canada, says federal health official


Coronavirus: Over 902,000 COVID-19 vaccine doses administered across Canada, says federal health official

A source from the Prime Minister’s Office tells Global News that it is expected Health Canada will change the doses from five to six. When that happens, Canada will hit its four million target with the same number of trays of vials being shipped by Pfizer.

However, if Health Canada does not give the green light, the source said Pfizer will increase the shipments of vials to fulfill its contractual obligation of four million, nonetheless.

Story continues below advertisement

As it stands, federal officials are “doing the math” with five doses per vial, Fortin said, while Pfizer is doing so with six doses.

“That decision (by Health Canada) has not been made yet, so that decision reflects in the data,” Fortin said.

“Planning figures can be misleading, but we will assure we have good, meaningful, bilateral discussions to assure them of what we’re currently thinking.”

Read more:
How can we get more vaccines faster? Experts say ‘it’s just not that easy’

The reduction stems, in part, from a production delay at Pfizer’s factory in Europe. The company is scaling up its manufacturing capacity in Belgium — a move it said would impact the vaccine’s production for a “short period.”

Canadian officials have maintained that the reduction in shipments for January and February would be made up when deliveries “ramp up” in March.

Fortin told reporters on Jan. 15, the day the European production delay was announced, that shipments would be reduced by an average of 50 per cent over four weeks.

He did, at the time, acknowledge that the brunt of the delivery reduction would be felt in late January.

“But Pfizer assures us they will recover from that quite significantly and rapidly,” he said at Thursday’s press conference.

Story continues below advertisement






3:26
Coronavirus: Anand says despite Pfizer delay, Canada to have about 20 million doses available by June


Coronavirus: Anand says despite Pfizer delay, Canada to have about 20 million doses available by June

Fortin and Prime Minister Justin Trudeau have both said they were confident the delays would be “temporary” and that Canada would still receive four million doses of Pfizer’s shot by the end of March

To date, Canada has received about 1,122,450 doses of both the Moderna and Pfizer vaccines, according to a vaccine tracker by the University of Saskatchewan. A tally by the Public Health Agency of Canada shows the total number of vaccines delivered as 1,119,225.

Pfizer has indicated to Canada that vaccine deliveries would also be impacted through February. The next two weeks will be lower than initially planned, Fortin said, with 79,000 doses next week and approximately 70,000 the second week of February.

From there, Fortin expects things to still scale up to meet the four million target.

Story continues below advertisement

But it’s a “long game,” Fortin added.

Canada has set a goal to obtain enough approved vaccines for anyone who wishes to be vaccinated by the end of September. Fortin maintained Thursday that he is confident that goal will be met.

Read more:
How can we get more vaccines faster? Experts say ‘it’s just not that easy’

Several provinces have already used up nearly all their vaccine supply and have been forced to push back their vaccination schedules.

This week, Ontario announced it would pause vaccinations of long-term care staff and essential caregivers due to upcoming delivery delays. Saskatchewan announced Sunday it had exhausted all the doses it had received so far, while Quebec said it had used up more than 90 per cent of its supply.

Concerns about the slow pace of the vaccine rollout are rising in Canada and around the world.






2:42
Canada ranks 18th on world stage for vaccine rollout


Canada ranks 18th on world stage for vaccine rollout

A recent analysis from The Economist Intelligence Unit (EIU) suggested Canada may not be on track for widespread vaccination by September 2021, which is when Trudeau has vowed everyone who wants a vaccine will be able to get one.

Story continues below advertisement

The researchers predict widespread vaccination won’t happen in Canada until mid-2022.

“Every government around the world has promised its population that they would get access to coronavirus vaccines soon. However, our index shows that this is not a realistic pledge,” Agathe Demarais, global forecasting director of the EIU and author of the report, told Global News in an email.

“Based on a host of indicators, including supply deals, production constraints, vaccine hesitancy, the size of the population, and the availability of healthcare workers, we believe that the immunization of 60-70% of the Canadian population will be completed in early 2022.”

Read more:
Canada’s September vaccine target could hinge on other approvals

The report ranked countries by their vaccine timelines to date and the assessed likelihood that they will hit those.

Canada came up on par with Brazil, while the United States and Europe were all on track for widespread vaccination by the end of this year.

Demarais notes that Canada’s unique and vast territory will be a “specific hurdle,” making it hard for vaccines to reach remote regions. Production delays, like the ones unfolding in Belgium, will also be part of the constraint, she said.

— with files from The Canadian Press and Global News’ David Akin, Rachel Gilmore and Amanda Connolly 

Advertisement

© 2021 Global News, a division of Corus Entertainment Inc.

Let’s block ads! (Why?)



Source link

Continue Reading

Business

Canada Goose to get into eyewear through deal with Marchon

Published

 on

 

TORONTO – Canada Goose Holdings Inc. says it has signed a deal that will result in the creation of its first eyewear collection.

The deal announced on Thursday by the Toronto-based luxury apparel company comes in the form of an exclusive, long-term global licensing agreement with Marchon Eyewear Inc.

The terms and value of the agreement were not disclosed, but Marchon produces eyewear for brands including Lacoste, Nike, Calvin Klein, Ferragamo, Longchamp and Zeiss.

Marchon plans to roll out both sunglasses and optical wear under the Canada Goose name next spring, starting in North America.

Canada Goose says the eyewear will be sold through optical retailers, department stores, Canada Goose shops and its website.

Canada Goose CEO Dani Reiss told The Canadian Press in August that he envisioned his company eventually expanding into eyewear and luggage.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:GOOS)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

A timeline of events in the bread price-fixing scandal

Published

 on

 

Almost seven years since news broke of an alleged conspiracy to fix the price of packaged bread across Canada, the saga isn’t over: the Competition Bureau continues to investigate the companies that may have been involved, and two class-action lawsuits continue to work their way through the courts.

Here’s a timeline of key events in the bread price-fixing case.

Oct. 31, 2017: The Competition Bureau says it’s investigating allegations of bread price-fixing and that it was granted search warrants in the case. Several grocers confirm they are co-operating in the probe.

Dec. 19, 2017: Loblaw and George Weston say they participated in an “industry-wide price-fixing arrangement” to raise the price of packaged bread. The companies say they have been co-operating in the Competition Bureau’s investigation since March 2015, when they self-reported to the bureau upon discovering anti-competitive behaviour, and are receiving immunity from prosecution. They announce they are offering $25 gift cards to customers amid the ongoing investigation into alleged bread price-fixing.

Jan. 31, 2018: In court documents, the Competition Bureau says at least $1.50 was added to the price of a loaf of bread between about 2001 and 2016.

Dec. 20, 2019: A class-action lawsuit in a Quebec court against multiple grocers and food companies is certified against a number of companies allegedly involved in bread price-fixing, including Loblaw, George Weston, Metro, Sobeys, Walmart Canada, Canada Bread and Giant Tiger (which have all denied involvement, except for Loblaw and George Weston, which later settled with the plaintiffs).

Dec. 31, 2021: A class-action lawsuit in an Ontario court covering all Canadian residents except those in Quebec who bought packaged bread from a company named in the suit is certified against roughly the same group of companies.

June 21, 2023: Bakery giant Canada Bread Co. is fined $50 million after pleading guilty to four counts of price-fixing under the Competition Act as part of the Competition Bureau’s ongoing investigation.

Oct. 25 2023: Canada Bread files a statement of defence in the Ontario class action denying participating in the alleged conspiracy and saying any anti-competitive behaviour it participated in was at the direction and to the benefit of its then-majority owner Maple Leaf Foods, which is not a defendant in the case (neither is its current owner Grupo Bimbo). Maple Leaf calls Canada Bread’s accusations “baseless.”

Dec. 20, 2023: Metro files new documents in the Ontario class action accusing Loblaw and its parent company George Weston of conspiring to implicate it in the alleged scheme, denying involvement. Sobeys has made a similar claim. The two companies deny the allegations.

July 25, 2024: Loblaw and George Weston say they agreed to pay a combined $500 million to settle both the Ontario and Quebec class-action lawsuits. Loblaw’s share of the settlement includes a $96-million credit for the gift cards it gave out years earlier.

Sept. 12, 2024: Canada Bread files new documents in Ontario court as part of the class action, claiming Maple Leaf used it as a “shield” to avoid liability in the alleged scheme. Maple Leaf was a majority shareholder of Canada Bread until 2014, and the company claims it’s liable for any price-fixing activity. Maple Leaf refutes the claims.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:L, TSX:MFI, TSX:MRU, TSX:EMP.A, TSX:WN)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Business

TD CEO to retire next year, takes responsibility for money laundering failures

Published

 on

 

TORONTO – TD Bank Group, which is mired in a money laundering scandal in the U.S., says chief executive Bharat Masrani will retire next year.

Masrani, who will retire officially on April 10, 2025, says the bank’s, “anti-money laundering challenges,” took place on his watch and he takes full responsibility.

The bank named Raymond Chun, TD’s group head, Canadian personal banking, as his successor.

As part of a transition plan, Chun will become chief operating officer on Nov. 1 before taking over the top job when Masrani steps down at the bank’s annual meeting next year.

TD also announced that Riaz Ahmed, group head, wholesale banking and president and CEO of TD Securities, will retire at the end of January 2025.

TD has taken billions in charges related to ongoing U.S. investigations into the failure of its anti-money laundering program.

This report by The Canadian Press was first published Sept. 19, 2024.

Companies in this story: (TSX:TD)

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version